TDH Statement on FDA Full Approval of Pfizer Covid-19 Vaccine

NASHVILLE, Tenn. - Today, the Food and Drug Administration (FDA) issued full authorization of the Pfizer-BioNTech COVID-19 vaccine for individuals age 16 and up. The vaccine remains under emergency use authorization (EUA) for those age 12-15 years and for the administration of the third dose option for individuals who are moderately or severely immunocompromised.

The full licensed approval from the FDA is given after more than 9 months of data review and continued case study. The Pfizer vaccine has been available in Tennessee since December 2020 with approximately 3.4 million Pfizer doses admi...